According to Arizton’s latest research report, the lipid-based pharma excipients market is growing at a CAGR of 5.63% during ...

The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic ...

Obesity is a significant risk factor for various metabolic diseases and, in many cases, causes ectopic fat accumulation (i.e.

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – ...

The following is a summary of "Lipid Metabolic Reprograming: the Unsung Hero in Breast Cancer Progression and Tumor ...

The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a ...

In biology, seeing can lead to understanding, and researchers in Professor Edward Boyden's lab at the McGovern Institute for ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

The Vietnam lipid market, estimated at USD 124.32 million in 2024, is projected to grow to USD 189.44 million by 2033, exhibiting a CAGR of 7.23% during the forecast period. This growth is primarily ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated ...